Merck & Company Inc (MRK)vsOSR Holdings Inc (OSRH)
MRK
Merck & Company Inc
$120.79
-1.42%
HEALTHCARE · Cap: $285.64B
OSRH
OSR Holdings Inc
$0.42
-1.12%
HEALTHCARE · Cap: $14.13M
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 2501916% more annual revenue ($65.77B vs $2.63M). MRK leads profitability with a 13.6% profit margin vs 0.0%. OSRH trades at a lower P/E of 13.4x. MRK earns a higher WallStSmart Score of 50/100 (D+).
MRK
Hold50
out of 100
Grade: D+
OSRH
Avoid25
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-49.3%
Fair Value
$80.88
Current Price
$120.79
$39.91 premium
Intrinsic value data unavailable for OSRH.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Strong operational efficiency at 38.6%
Generating 2.9B in free cash flow
Reasonable price relative to book value
Conservative balance sheet, low leverage
Attractively priced relative to earnings
Areas to Watch
Premium valuation, high expectations priced in
4.9% revenue growth
Elevated debt levels
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -14.7% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bull Case : OSRH
The strongest argument for OSRH centers on Price/Book, Debt/Equity, P/E Ratio.
Bear Case : MRK
The primary concerns for MRK are P/E Ratio, Revenue Growth, Debt/Equity.
Bear Case : OSRH
The primary concerns for OSRH are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
OSRH carries more volatility with a beta of 0.61 — expect wider price swings.
MRK is growing revenue faster at 4.9% — sustainability is the question.
MRK generates stronger free cash flow (2.9B), providing more financial flexibility.
Monitor DRUG MANUFACTURERS - GENERAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
MRK scores higher overall (50/100 vs 25/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →OSR Holdings Inc
HEALTHCARE · BIOTECHNOLOGY · USA
OSR Holdings Inc. is a prominent provider of integrated managed services, specializing in asset management and financial advisory solutions tailored for institutional clients. Leveraging cutting-edge technology and strategic collaborations, the company enhances operational efficiency while expanding its diverse service portfolio. Committed to sustainable growth and client-centric value creation, OSR Holdings distinguishes itself through innovation and exceptional service quality. With a proactive approach to emerging market opportunities, the firm upholds a robust risk management framework, ensuring long-term stability and success for its stakeholders.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?